Onartuzumab

Onartuzumab
Onartuzumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target scatter factor receptor kinase
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 1133766-06-9 N
ATC code None
UNII MS1J9720WC YesY
Chemical data
Formula C4422H6820N1168O1363S31 
Mol. mass 99.1 kDa
 N(what is this?)  (verify)

Onartuzumab is a humanized monoclonal antibody designed for the treatment of cancer.[1]

Onartuzumab was developed by Genentech, Inc.

References

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Onartuzumab". American Medical Association. http://www.ama-assn.org/resources/doc/usan/onartuzumab.pdf.